Clinical Research
News & Careers
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile


Orexo AB 

Box 303

Uppsala    SE-751 05  Sweden
Phone: 46-0-18-780-88-00 Fax: 46-0-18-780-88-88



 Company News
Orexo AB (ORXOF) Has Successfully Completed Its Private Placement Of Approx. SEK 346.5 Million 8/29/2014 11:36:57 AM
Orexo AB (ORXOF) Enhances Commercial Focus And Operating Efficiencies 8/20/2014 11:45:05 AM
OX-MPI Project Returned To Orexo AB (ORXOF) 8/6/2014 9:57:28 AM
Number Of Shares And Votes In Orexo AB (ORXOF) 7/31/2014 11:11:35 AM
Orexo AB (ORXOF): Interim Report January-June 2014 7/11/2014 9:39:01 AM
Orexo AB (ORXOF) Added To Russell Global Index 6/30/2014 11:22:47 AM
Orexo AB (ORXOF) Added To Russell Global Index 6/30/2014 8:10:12 AM
Orexo AB (ORXOF) Commences Patent Infringement Litigation Against Actavis (ACT) 6/27/2014 7:23:12 AM
Orexo AB (ORXOF) Release: Top-Line Data From A Phase 3 Clinical Trial Demonstrates That Zubsolv® Is As Effective As Suboxone® Film In The Treatment Of Opioid Dependence 6/25/2014 8:14:57 AM
Orexo AB (ORXOF) Release: Positive Top-Line Results From Two Phase 3 Clinical Trials That Assessed ZubsolvĀ® For Induction Of Buprenorphine Maintenance Therapy 6/23/2014 7:44:03 AM